Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colitis, Ulcerative 3Arthritis, Rheumatoid 3Spondylitis, Ankylosing 1Recurrence 1Prostatic Neoplasms 1Lymphoma 1Inflammatory Bowel Diseases 1Diabetes Mellitus, Type 1 1Crohn Disease 1

Interventions

Tea 3Polyethylene Glycols 3Infliximab 3MEDI2070 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2sodium phosphate 1prucalopride 1polyethylene glycol 400 1picosulfate sodium 1golimumab 1cabozantinib 1Surgical Tape 1Standard of Care 1Spectrum Analysis, Raman 1Specimen Handling 1Pneumococcal Vaccines 1Platinum Compounds 1Passive Cutaneous Anaphylaxis 1Papillomavirus Vaccines 1Oxygen 1Nivolumab 1Neomycin 1Narrow Band Imaging 1Morphine 1Metronidazole 1Medical Marijuana 1Laparoscopy 1Ipilimumab 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Inflammatory Bowel Diseases × golimumab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡